Clinical Trial: A Bioequivalence Study of CT-L02 Compared to Co-administration (CTL0201 and CTL0202) in Healthy Volunteers

U.S., Aug. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07128654) titled 'A Bioequivalence Study of CT-L02 Compared to Co-administration (CTL0201 and CTL0202) in Healthy Volunteers' on Aug. 14.

Brief Summary: This is a randomized, open, single-dose, crossover-design, phase I study to evaluate the safety and pharmacokinetics after co-administration of CTL0201 and CTL0202 or administration of CT-L02 in healthy volunteers.

Study Start Date: Aug., 2025

Study Type: INTERVENTIONAL

Condition: Healthy

Intervention: DRUG: CTL02

FDC tablet, single dose, oral administration

DRUG: CTL0201

Nesina, tablet, single dose, oral administration

DRUG: CTL0202

Jardiance, tablet, single dose, oral administration

Rec...